Address

Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, Schöpfstraße 41, 6020 Innsbruck, Austria

Josef Fritz

Postdoc

Medical University of Innsbruck

Biography

Josef Fritz is a postdoctoral researcher and biostatistician. His research focuses on the relationship between metabolic disorders and chronic diseases, particularly cardiovascular disease, cancer and kidney disease, with additional expertise in causal inference and mediation analysis. Dr. Fritz has held research positions in the USA and Sweden, and has received awards such as the Austrian Society of Nephrology Prize (2022) and OeGEPI Best Paper Award (2020).

Selected publications

  • Fritz J, Jochems SHJ, Bjørge T, Wood AM, Häggström C, Ulmer H, Nagel G, Zitt E, Engeland A, Harlid S, Drake I, Stattin P, Stocks T. Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts. Br J Cancer. 2024 Feb;130(2):308-316.
  • Fritz J, Huang T, Depner CM, Zeleznik OA, Cespedes Feliciano EM, Li W, Stone KL, Manson JE, Clish C, Sofer T, Schernhammer E, Rexrode K, Redline S, Wright KP, Vetter C. Sleep duration, plasma metabolites, and obesity and diabetes: a metabolome-wide association study in US women. Sleep. 2023 Jan 11;46(1):zsac226.
  • Fritz J, Brozek W, Concin H, Nagel G, Kerschbaum J, Lhotta K, Ulmer H, Zitt E. The Association of Excess Body Weight with Risk of ESKD Is Mediated Through Insulin Resistance, Hypertension, and Hyperuricemia. J Am Soc Nephrol. 2022 Jul;33(7):1377-1389.
  • Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, Concin H, Teleka S, Tretli S, Gylling B, Lang A, Stattin P, Stocks T, Ulmer H. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol. 2020 Feb 1;49(1):193-204.

  1. 2017

    PhD in Genetics and Genomics

    Medical University of Innsbruck, Innsbruck, Austria
  2. 2008

    Dipl-Ing. in Technical Mathematics

    Leopold-Franzens-University of Innsbruck, Innsbruck, Austria

  1. Since 2022
    Associate Researcher (part time)
    Lund University, Sweden
  2. 2021
    Visiting researcher
    Department of Clinical Sciences, Lund University, Sweden
  3. Since 2020
    Postdoctoral researcher
    Medical University of Innsbruck, Innsbruck, Austria
  4. 2018-2020
    Postdoctoral researcher
    Department of Integrative Physiology, University of Colorado, Boulder, USA
  5. 2017-2018
    Postdoctoral researcher
    Medical University of Innsbruck, Innsbruck, Austria
  6. 2013-2017
    PhD student and researcher
    Medical University of Innsbruck, Innsbruck, Austria
  7. 2008-2013
    Clinical Trial Biostatistician
    , Assign Data Management and Biostatistics GmbH, Innsbruck

  • 2022
    ÖGN-Förderpreis for the publication “The Association of Excess Body Weight with Risk of ESKD Is Mediated Through Insulin Resistance, Hypertension, and Hyperuricemia” (JASN 2022;33:1377-1389)
    Austrian Society of Nephrology
  • 2020
    Best Paper Award 2020 for the publication “The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers" (Int J Epidemiol 2020;49:193-204)
    OeGEPI (Austrian Society of Epidemiology)
  • 2018-2020
    US Fellowship of the Max Kade Foundation
    Department of Integrative Physiology, University of Boulder, Colorado, USA